Swanson Regg E.
Known title: DirectorCIK: 0001412473
Swanson Regg E.'s purchase track record
Swanson Regg E. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/6/2022 | USPH | $78K | +17.2% | +26.5% | +2.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| USPH | ▲ Buy | Grant | 2,306 | $142K | 5/19/2026 | View on chart |
| USPH | ▲ Buy | Grant | 1,882 | $0 | 5/20/2025 | View on chart |
| USPH | ▲ Buy | Grant | 1,424 | $0 | 5/20/2024 | View on chart |
| USPH | ▲ Buy | Grant | 1,600 | $0 | 5/16/2023 | View on chart |
| USPH | ▲ Buy | Open Market | 1,000 | $78K | 9/6/2022 | View on chart |
| USPH | ▲ Buy | Grant | 1,600 | $0 | 5/16/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
USPH Appoints New CFO and Board Member Amid Earnings Review
U.S. Physical Therapy announced the appointment of a new Chief Financial Officer and a new board member, Myra Davis. These leadership changes are occurring alongside the release of the company's Q2 2026 earnings call transcript. The news has drawn attention to potential shifts in the company's cash flow management and financial narrative.
USPH Appoints New CFO and Board Member Amid Earnings Review. U.S. Physical Therapy announced the appointment of a new Chief Financial Officer and a new board member, Myra Davis. These leadership changes are occurring alongside the release of the company's Q2 2026 earnings call transcript. The news has drawn attention to potential shifts in the company's cash flow management and financial narrative.